Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Sep 24;12(10):2737.
doi: 10.3390/cancers12102737.

Loco-Regional and Systemic Chemotherapies for Hepato-Pancreatic Tumors: Integrated Treatments

Girolamo Ranieri  1 , Carmelo Laface  1
Affiliations
Editorial

Loco-Regional and Systemic Chemotherapies for Hepato-Pancreatic Tumors: Integrated Treatments

Girolamo Ranieri et al. Cancers (Basel). .

Abstract

This Special Issue of Cancers, titled "Loco-Regional Arterial Chemotherapies Alone or in Combination with Systemic Treatments for Primary and Secondary Hepato-Pancreatic Tumors", focuses on new possible strategies to treat only liver disease (or mainly liver disease) through the combination of loco-regional and systemic chemotherapies [...].

Keywords: hepatic arterial infusion; loco-regional therapies; pancreatic cancer; primary and metastatic liver tumors; transarterial chemoembolization.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Foster J.H. Treatment of metastatic disease of the liver: A skeptic’s view. Semin. Liver Dis. 1984;4:170–179. doi: 10.1055/s-2008-1040656. - DOI - PubMed
    1. Khan S.A., Tavolari S. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019;39(Suppl. S1):19–31. doi: 10.1111/liv.14095. - DOI - PubMed
    1. Benson A.B., Venook A.P., Al-Hawary M.M., Cederquist L., Chen Y.J., Ciombor K.K., Cohen S., Cooper H.S., Deming D., Engstrom P.F., et al. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J. Natl. Compr. Cancer Netw. JNCCN. 2018;16:359–369. doi: 10.6004/jnccn.2018.0021. - DOI - PMC - PubMed
    1. Maisonneuve P. Epidemiology and burden of pancreatic cancer. Presse Med. 2019;48:e113–e123. doi: 10.1016/j.lpm.2019.02.030. - DOI - PubMed
    1. Conroy T., Desseigne F., Ychou M., Bouché O., Guimbaud R., Bécouarn Y., Adenis A., Raoul J.L., Gourgou-Bourgade S., de la Fouchardière C., et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N. Engl. J. Med. 2011;364:1817–1825. doi: 10.1056/NEJMoa1011923. - DOI - PubMed

Publication types

LinkOut - more resources